By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282


SEARCH JOBS


Industry
Biotechnology






Company News
Immunomedics, Inc. (IMMU) Release: Scientific Data On Epratuzumab In Systemic Lupus Erythematosus To Be Presented At EULAR 2014 6/9/2014 9:11:24 AM
Immunomedics, Inc. (IMMU) Announces Orphan Drug Designation For IMMU-132 For Pancreatic Cancer Therapy 6/9/2014 8:59:56 AM
Immunomedics, Inc. (IMMU) Reports Development Of Improved Cancer Immunotherapy At The 2014 Annual Meeting Of The American Society of Clinical Oncology 6/2/2014 9:50:09 AM
Immunomedics, Inc. (IMMU) Reports Final Efficacy Results Of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan In Patients With Metastatic Pancreatic Cancer 6/2/2014 9:47:50 AM
Immunomedics, Inc. (IMMU) Reports IMMU-130 Is Active In Patients With Irinotecan-Refractory Colorectal Cancer 6/2/2014 9:21:27 AM
Immunomedics, Inc. (IMMU) To Present At Upcoming Healthcare Conferences 5/29/2014 9:21:21 AM
Immunomedics, Inc. (IMMU) Reports Results With IMMU-132 In Patients With Pancreatic Cancer 5/21/2014 9:27:02 AM
Immunomedics, Inc. (IMMU) Reports Results With IMMU-132 In Patients With Pancreatic Cancer 5/20/2014 11:53:30 AM
Immunomedics, Inc. (IMMU) Reports Updated Results With 90Y-Clivatuzumab Tetraxetan In Patients With Metastatic Pancreatic Cancer 5/19/2014 9:19:53 AM
Immunomedics, Inc. (IMMU) To Present Updated Phase 2 Results From Antibody-Drug Conjugate Programs At 2014 American Society of Clinical Oncology 5/15/2014 11:34:04 AM
12345678910...
//-->